Naturally upregulated by the induction of estrogen, circPGR aggravates breast cancer progression by suppressing its target, miR-301a-5p, which partially binds to CDK1, CDK6, and checkpoint kinase 2 (CHEK2) mRNA. The gene discussed is CHEK2; the disease is breast cancer.